BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 17936533)

  • 1. [In vitro activity of levofloxacin against Escherichia coli strains in acute pyelonephritis, in France in 2005].
    Soussy CJ; Lascols C; Dib-Smahi C;
    Med Mal Infect; 2007 Nov; 37(11):773-5. PubMed ID: 17936533
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Evaluation of levofloxacin susceptibility against strains isolated from lower urinary tract infections in the community].
    Weber P; Dib C; Durand C; Moniot-Ville N
    Pathol Biol (Paris); 2005 Mar; 53(2):125-8. PubMed ID: 15708658
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Community-acquired urinary tract infections in 15 to 65 years old female patients in France. Susceptibility of E. coli according to history: AFORCOPI-BIO network 2003].
    de Mouy D; Fabre R; Cavallo JD; Arzouni JP; Baynat M; Bicart-See A; Berges JL; Bouilloux JP; Galinier JL; Garrabé E; Gontier P; Grillet N; Lepargneur JP; Naepels I; Payro G;
    Med Mal Infect; 2007 Sep; 37(9):594-8. PubMed ID: 17258415
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification and pretherapy susceptibility of pathogens in patients with complicated urinary tract infection or acute pyelonephritis enrolled in a clinical study in the United States from November 2004 through April 2006.
    Peterson J; Kaul S; Khashab M; Fisher A; Kahn JB
    Clin Ther; 2007 Oct; 29(10):2215-21. PubMed ID: 18042477
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Susceptibility of Escherichia coli to the amoxycillin-clavulanate combination: which recommendations should be used to provide relevant information to clinicians?
    Patry I; Hocquet D; Talon D; Plesiat P; Bertrand X
    Clin Microbiol Infect; 2005 Mar; 11(3):237-40. PubMed ID: 15715724
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Urinary bactericidal activity of single doses (250, 500, 750 and 1000 mg) of levofloxacin against fluoroquinolone-resistant strains of Escherichia coli.
    Stein GE; Schooley SL; Nicolau DP
    Int J Antimicrob Agents; 2008 Oct; 32(4):320-5. PubMed ID: 18715762
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk factors for quinolone-resistance in women presenting with Escherichia coli acute pyelonephritis.
    Bedoin M; Cazorla C; Lucht F; Berthelot P; Boyer M; Carricajo A; Guérin T; Viallon A
    Med Mal Infect; 2014 May; 44(5):206-16. PubMed ID: 24794820
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro activity of prulifloxacin against Escherichia coli isolated from urinary tract infections and the biological cost of prulifloxacin resistance.
    Gualco L; Schito AM; Schito GC; Marchese A
    Int J Antimicrob Agents; 2007 Jun; 29(6):679-87. PubMed ID: 17363225
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The antimicrobial susceptibility of Escherichia coli isolated in eastern area of Romania. A surveillance study.
    Poiată A; Tuchilus C; Bădicut I; Grigore L; Filipiuc S; Adomniţei C; Buiuc D
    Roum Arch Microbiol Immunol; 1999; 58(2):177-84. PubMed ID: 11845455
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Resistance of Escherichia coli isolated from the urinary tract to amoxicillin-clavulanic acid and other antibiotics].
    Ferjani A; Marzouk M; Ben Moussa F; Boukadida J
    Med Mal Infect; 2010 Mar; 40(3):161-4. PubMed ID: 19616395
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Comparative susceptibility evolution in Escherichia coli from urinary tract infections in outpatients and inpatients at Perpignan hospital in 2002 and 2004].
    Lemort ML; Neuville S; Medus M; Gueudet P; Saada M; Aumaître H; Lecaillon E
    Pathol Biol (Paris); 2006; 54(8-9):427-30. PubMed ID: 17027183
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Short communication: comparison of susceptibilities of Escherichia coli urinary tract isolates against fosfomycin tromethamine and different antibiotics].
    Aykut Arca E; Karabiber N
    Mikrobiyol Bul; 2007 Jan; 41(1):115-9. PubMed ID: 17427560
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Evaluation of a new and rapid antibiotic sensitivity method testing for Enterobacteriaceae responsible for urinary infections].
    Laudat P; Crouzier C
    Pathol Biol (Paris); 1997 May; 45(5):389-93. PubMed ID: 9296090
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics/pharmacodynamics of levofloxacin 750 mg once daily in young women with acute uncomplicated pyelonephritis.
    Nicolle L; Duckworth H; Sitar D; Bryski L; Harding G; Zhanel G
    Int J Antimicrob Agents; 2008 Mar; 31(3):287-9. PubMed ID: 18155885
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Surveillance of antimicrobial resistance among nosocomial gram-negative pathogens from 15 teaching hospitals in China in 2005].
    Yang QW; Xu YC; Chen MJ; Hu YJ; Ni YX; Sun JY; Yu YS; Kong HS; He L; Wu WY; Ye HF; Yang YM; Zhu LN; Guo SH; Ji P; Zhu ZH; Ren JK; Zhang LX; Sun ZY; Zhu XH; Tong MQ; Zhao WS; Mei YN; Liu Y; Zhang ZJ; Duan Q; Li D; Liu PP; Wang J; Han LX; Wang H; Xie XL
    Zhonghua Yi Xue Za Zhi; 2007 Oct; 87(39):2753-8. PubMed ID: 18167265
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activity of ertapenem and other antimicrobials against ESBL-producing enterobacteria isolated from urine in patients from Madrid.
    Tamayo J; Orden B; Cacho J; Cuadros J; Gomez-Garces JL; Alos JI
    Rev Esp Quimioter; 2007 Sep; 20(3):334-8. PubMed ID: 18080031
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Evaluation of an automated system in bacteriology. Application to bacteriological susceptibility tests].
    Philippin JL; Pitton JS; Fournier P
    Pathol Biol (Paris); 1991 May; 39(5):471-9. PubMed ID: 1881677
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antimicrobial susceptibility of well-characterised multiresistant CTX-M-producing Escherichia coli: failure of automated systems to detect resistance to piperacillin/tazobactam.
    Pitout JD; Le P; Church DL; Gregson DB; Laupland KB
    Int J Antimicrob Agents; 2008 Oct; 32(4):333-8. PubMed ID: 18701262
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of disc diffusion, Etest and agar dilution for susceptibility testing of colistin against Enterobacteriaceae.
    Maalej SM; Meziou MR; Rhimi FM; Hammami A
    Lett Appl Microbiol; 2011 Nov; 53(5):546-51. PubMed ID: 21895730
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibiotic therapy for acute uncomplicated pyelonephritis in women. Take resistance into account.
    Prescrire Int; 2014 Dec; 23(155):296-300. PubMed ID: 25629148
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.